You are here:

lercanidipine 20mg tablet (Zanidip)


Following an abbreviated submission

lercanidipine 20mg tablet (Zanidip) is accepted for use in NHS Scotland for the treatment of mild to moderate essential hypertension in patients for whom this is an appropriate antihypertensive agent.

This new strength allows a reduction in the number of tablets administered at the maximum dose, at reduced cost compared with the formulation available previously

Drug Details

Drug Name: lercanidipine 20mg tablet (Zanidip)
SMC Drug ID: 315/06
Manufacturer: Recordati Pharmaceuticals
Indication: Hypertension
BNF Category:
Sub Category: 2.6 Nitrates*** calcium-channel blockers*** and other antianginal drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 October 2006